Sensipar (Mimpara) 30 mg 84 Tablets (Cinacalcet) Buy Online

Sensipar (Mimpara) 30 mg 84 Tablets (Cinacalcet) Buy Online
Product Code: cinacalcet
Availability: In Stock
Price: $799.00
Ex Tax: $799.00
Qty:     - OR -   Add to Wish List
Add to Compare

Mimpara (active ingredient's chemical name is cinacalcet) 30mg 28 film tablets, is a new generation medication which is used for the treatment of increased amounts of a certain hormone (parathyroid) in people with long-term kidney disease who are on dialysis. It is also used to treat increased amounts of calcium in people with an overactive parathyroid gland or in people with cancer of the parathyroid gland. Mimpara (cinacalcet) 30mg works by decreasing the amount of parathyroid hormone, calcium, and phosphorus in your body. Having the right amount of these substances in your body helps to prevent bone disease. 

Sensipar (cinacalcet) decreases levels of parathyroid hormone (PTH), calcium, and phosphorous in the body.

Sensipar is used to treat hyperparathyroidism (overactive functioning of the parathyroid glands) in people who are on long-term dialysis for kidney disease.

Sensipar is also used to treat hypercalcemia (high levels of calcium in the blood) in people with cancer of the parathyroid gland, and in people with overactive parathyroid glands that cannot be treated surgically. 

Sensipar works best if you take it with food or shortly after eating a meal. Do not crush or break a tablet. Swallow the pill whole.

Call your doctor at once if you have a serious side effect such as numbness or tingly feeling around your mouth, fast or slow heart rate, muscle tightness or contraction, overactive reflexes, seizure, feeling short of breath, swelling, rapid weight gain, or feeling like you might pass out.

To be sure Sensipar is helping your condition, your blood may need to be tested often. Visit your doctor regularly

Before taking this medicine
You should not use Sensipar if you are allergic to cinacalcet, or if you have:

low levels of calcium in your blood (hypocalcemia).

To make sure Sensipar is safe for you, tell your doctor if you have:

high or low blood pressure;

heart disease, heart failure, heart rhythm disorder;

liver disease;

a history or seizures; or

if you have kidney disease and you are not on dialysis.

It is not known whether Sensipar will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

It is not known whether cinacalcet passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are taking this medicine.

Sensipar is not approved for use by anyone younger than 18 years old.

How should I take Sensipar?
Take Sensipar exactly as prescribed by your doctor. Follow all directions on your prescription label. Your doctor may occasionally change your dose to make sure you get the best results. Do not use this medicine in larger or smaller amounts or for longer than recommended.

Sensipar works best if you take it with food or shortly after eating a meal.

Do not crush or break a tablet. Swallow the pill whole.

To be sure your calcium and phosphorous levels do not get too low, your blood will need to be tested 1 week after you start taking Sensipar or whenever your dose is changed. You may also need blood tests on a regular basis during treatment.

Store at room temperature away from moisture, light, and heat.

Sensipar dosing information
Usual Adult Dose for Secondary Hyperparathyroidism:

Initial dose: 30 mg orally once a day (cinacalcet should be titrated no more frequently than every 2 to 4 weeks through sequential doses of 30, 60, 90, 120, and 180 mg orally once daily).
Maintenance dose: 30 to 180 mg orally once a day
Maximum dose: 180 mg once a day

Approved indication: Secondary hyperparathyroidism in patients with chronic kidney disease on dialysis

Usual Adult Dose for Hypercalcemia of Malignancy:

Initial dose: 30 mg orally twice a day (Titrate dose every 2 to 4 weeks through sequential doses of 30 mg twice daily, 60 mg twice daily, 90 mg twice daily, and 90 mg 3 or 4 times daily).
Maintenance dose: 60 mg to 360 mg orally per day
Maximum dose: 90 mg four times a day

Approved indication: Parathyroid carcinoma and primary hyperparathyroidism who are unable to undergo parathyroidectomy

Usual Adult Dose for Primary Hyperparathyroidism:

Initial dose: 30 mg orally twice a day (Titrate dose every 2 to 4 weeks through sequential doses of 30 mg twice daily, 60 mg twice daily, 90 mg twice daily, and 90 mg 3 or 4 times daily).
Maintenance dose: 60 mg to 360 mg orally per day
Maximum dose: 90 mg four times a day

Approved indication: Parathyroid carcinoma and primary hyperparathyroidism who are unable to undergo parathyroidectomy

Write a review

Your Name:


Your Review: Note: HTML is not translated!

Rating: Bad           Good

Enter the code in the box below: